Thank you, Madam Chair.
Welcome, everybody. Thank you for your interest and for assisting us in having good public policy with this bill.
In the previous panel there was a lot of discussion about whether hazards the public should be protected against should include chronic toxicity and therefore should include carcinogens or compounds that would impact reproductive health. It was pointed out that measures are in place in California, in other places, and in Europe.
I have a question regarding the statment on page 4 of the Canadian Consumer Product Safety Coalition brief. Would it make sense, then, when you're calling for an increased alignment of international safety standards and procedures—something I spoke about directly earlier because I think that's important for small business and large business alike—to include the phase-out of carcinogens and endocrine disruptors in parallel or harmonized with the regimes that do that in different countries, in Europe, or in California?